SCHEMBL557011

SCHEMBL557011

O=[PH2]Oc1ccc(C(=C(C(=O)O)c2cccc(Cl)c2Cl)C(Cl)(Cl)Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2C9 P11712 1/20 0.33
P2RX7 Q99572 2/20 0.32
PKM P14618 3/20 0.31
ALDH1A1 P00352 2/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
ATM Q13315 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
POLB P06746 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.31
JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL556417 0.79 CA1 (0.37) TSHRERCC5FEN1KMT2AL3MBTL1
SCHEMBL556295 0.69 SMN1; SMN2 (0.32) TSHRERCC5FEN1KMT2AL3MBTL1
SCHEMBL1889955 0.64 KMT2A (0.57) TSHRERCC5FEN1KMT2AL3MBTL1
SCHEMBL11652748 0.64 TSHR (0.61) TSHRERCC5FEN1KMT2AL3MBTL1
SCHEMBL9422340 0.64 KMT2A (0.56) TSHRKMT2AL3MBTL1MAPTLMNA
SCHEMBL6516952 0.64 KMT2A (0.56) TSHRKMT2AL3MBTL1MAPTLMNA
SCHEMBL7032023 0.63 TSHR (0.71) TSHRERCC5FEN1L3MBTL1CYP2C9
SCHEMBL7547483 0.62 TSHR (0.69) TSHRERCC5FEN1KMT2AL3MBTL1
SCHEMBL97298 0.61 TSHR (1.00) TSHRERCC5FEN1KMT2AMAPT
SCHEMBL29904615 0.61 TSHR (1.00) TSHRERCC5FEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF STAT3, JAK2, STAT6 TSHR 1358/4885ERCC5 4287/4885FEN1 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.